Luke Evnin
Director at Werewolf Therapeutics, Inc. (HOWL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 8SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 35,770107,429 held (−25%) | $0.32 | $11K | +206.2% |
| Jul 8SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 107,429 | $0.31 | $33K | +216.1% |
| Jun 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 157,084143,199 held (−52%) | $0.30 | $47K | +226.7% |
| Jun 10SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 76,928300,283 held (−20%) | $0.37 | $28K | +164.9% |
| Jun 8SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 20,072462,704 held (−4%) | $0.44 | $9K | +122.7% |
| Jun 8SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 24,946437,758 held (−5%) | $0.40 | $10K | +145.0% |
| Jun 8SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 60,547377,211 held (−14%) | $0.40 | $24K | +145.0% |
| Jun 3SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 80,459542,120 held (−13%) | $0.47 | $38K | +108.5% |
| Jun 3SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 29,595512,525 held (−5%) | $0.45 | $13K | +117.8% |
| Jun 3SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 29,749482,776 held (−6%) | $0.42 | $12K | +133.3% |
| May 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 80,852682,833 held (−11%) | $0.48 | $39K | +104.2% |
| May 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 27,698655,135 held (−4%) | $0.46 | $13K | +113.0% |
| May 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 32,556622,579 held (−5%) | $0.45 | $15K | +117.8% |
| May 26SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 36,387919,060 held (−4%) | $0.42 | $15K | +133.3% |
| May 26SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 87,425831,635 held (−10%) | $0.45 | $39K | +117.8% |
| May 26SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 67,950763,685 held (−8%) | $0.47 | $32K | +108.5% |
| May 20SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 22,1841,104,312 held (−2%) | $0.50 | $11K | +96.0% |
| May 20SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 62,9701,041,342 held (−6%) | $0.45 | $28K | +117.8% |
| May 20SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 85,895955,447 held (−8%) | $0.43 | $37K | +127.9% |
| May 13SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 44,6791,126,496 held (−4%) | $0.54 | $24K | +81.5% |
| May 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 305,7411,273,008 held (−19%) | $0.70 | $214K | +40.0% |
| May 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 33,9481,239,060 held (−3%) | $0.67 | $23K | +46.3% |
| May 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 67,8851,171,175 held (−5%) | $0.64 | $43K | +53.1% |
| May 7SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 6,8601,672,470 held (−0%) | $0.69 | $5K | +42.0% |
| May 7SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 14,6351,657,835 held (−1%) | $0.66 | $10K | +48.5% |
| May 7SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 79,0861,578,749 held (−5%) | $0.63 | $50K | +55.6% |
| May 4SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 168,2621,785,687 held (−9%) | $0.72 | $121K | +36.1% |
| May 4SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 58,3941,727,293 held (−3%) | $0.73 | $43K | +34.2% |
| May 4SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 47,9631,679,330 held (−3%) | $0.72 | $35K | +36.1% |
| Apr 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 53,9402,105,920 held (−2%) | $0.85 | $46K | +15.3% |
| Apr 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 95,4122,010,508 held (−5%) | $0.73 | $70K | +34.2% |
| Apr 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 56,5591,953,949 held (−3%) | $0.69 | $39K | +42.0% |
| Jan 20SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 38,7822,159,860 held (−2%) | $0.54 | $21K | +81.5% |
| Jan 15SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 43,1982,266,671 held (−2%) | $0.55 | $24K | +78.2% |
| Jan 15SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 30,6162,236,055 held (−1%) | $0.57 | $17K | +71.9% |
| Jan 15SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 37,4132,198,642 held (−2%) | $0.55 | $21K | +78.2% |
| Jan 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 7,7162,393,527 held (−0%) | $0.63 | $5K | +55.6% |
| Jan 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 24,6782,368,849 held (−1%) | $0.61 | $15K | +60.7% |
| Jan 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 58,9802,309,869 held (−2%) | $0.57 | $34K | +71.9% |
| Jan 7SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 18,3782,453,919 held (−1%) | $0.64 | $12K | +53.1% |
| Jan 7SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 40,7612,413,158 held (−2%) | $0.65 | $26K | +50.8% |
| Jan 7SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 11,9152,401,243 held (−0%) | $0.64 | $8K | +53.1% |
| Jan 2SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 34,8472,515,827 held (−1%) | $0.61 | $21K | +60.7% |
| Jan 2SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 24,9622,490,865 held (−1%) | $0.62 | $15K | +58.1% |
| Jan 2SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 18,5682,472,297 held (−1%) | $0.63 | $12K | +55.6% |
| Dec 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 59,3072,782,650 held (−2%) | $0.69 | $41K | +42.0% |
| Dec 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 71,4282,711,222 held (−3%) | $0.63 | $45K | +55.6% |
| Dec 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 16,3102,694,912 held (−1%) | $0.65 | $11K | +50.8% |
| Dec 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 35,6322,659,280 held (−1%) | $0.63 | $22K | +55.6% |
| Dec 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 108,6062,550,674 held (−4%) | $0.61 | $66K | +60.7% |
| Dec 17SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 23,6402,866,488 held (−1%) | $1.07 | $25K | -8.4% |
| Dec 17SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 14,5482,851,940 held (−1%) | $1.05 | $15K | -6.7% |
| Dec 17SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 9,9832,841,957 held (−0%) | $1.14 | $11K | -14.0% |
| Dec 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 37,1042,935,995 held (−1%) | $1.06 | $39K | -7.5% |
| Dec 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 28,0092,907,986 held (−1%) | $1.07 | $30K | -8.4% |
| Dec 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 17,8582,890,128 held (−1%) | $1.08 | $19K | -9.3% |
| Dec 9SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 16,5683,051,710 held (−1%) | $0.97 | $16K | +1.0% |
| Dec 9SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 34,0413,017,669 held (−1%) | $0.99 | $34K | -1.0% |
| Dec 9SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 44,5702,973,099 held (−1%) | $1.01 | $45K | -3.0% |
| Dec 4SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 38,0433,158,420 held (−1%) | $0.89 | $34K | +10.1% |
| Dec 4SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 36,7263,121,694 held (−1%) | $0.87 | $32K | +12.6% |
| Dec 4SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 53,4163,068,278 held (−2%) | $0.97 | $52K | +1.0% |
| Dec 1SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 38,9783,248,573 held (−1%) | $0.98 | $38K | +0.0% |
| Dec 1SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 13,0143,235,559 held (−0%) | $0.99 | $13K | -1.0% |
| Dec 1SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 39,0963,196,463 held (−1%) | $0.94 | $37K | +4.3% |
| Nov 25SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 41,2873,371,840 held (−1%) | $0.83 | $34K | +18.1% |
| Nov 25SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 56,9923,314,848 held (−2%) | $0.98 | $56K | +0.0% |
| Nov 25SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 27,2973,287,551 held (−1%) | $0.92 | $25K | +6.5% |
| Nov 20SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 33,7763,482,104 held (−1%) | $0.93 | $31K | +5.4% |
| Nov 20SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 42,5663,439,538 held (−1%) | $0.94 | $40K | +4.3% |
| Nov 20SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 26,4113,413,127 held (−1%) | $0.89 | $24K | +10.1% |
| Nov 17SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 58,3723,592,061 held (−2%) | $0.98 | $57K | +0.0% |
| Nov 17SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 39,5603,552,501 held (−1%) | $0.93 | $37K | +5.4% |
| Nov 17SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 36,6213,515,880 held (−1%) | $0.95 | $35K | +3.2% |
| Nov 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 43,9503,743,524 held (−1%) | $1.11 | $49K | -11.7% |
| Nov 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 31,1723,712,352 held (−1%) | $1.18 | $37K | -16.9% |
| Nov 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 35,8183,676,534 held (−1%) | $1.14 | $41K | -14.0% |
| Nov 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 26,1013,650,433 held (−1%) | $1.09 | $28K | -10.1% |
| Nov 6SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 90,1643,853,195 held (−2%) | $1.22 | $110K | -19.7% |
| Nov 6SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 30,7743,822,421 held (−1%) | $1.22 | $38K | -19.7% |
| Nov 6SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 34,9473,787,474 held (−1%) | $1.21 | $42K | -19.0% |
| Nov 3SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 55,7954,076,920 held (−1%) | $1.43 | $80K | -31.5% |
| Nov 3SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 73,1924,003,728 held (−2%) | $1.28 | $94K | -23.4% |
| Nov 3SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 60,3693,943,359 held (−2%) | $1.29 | $78K | -24.0% |
| Oct 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 46,6644,263,196 held (−1%) | $1.72 | $80K | -43.0% |
| Oct 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 44,3274,218,869 held (−1%) | $1.64 | $73K | -40.2% |
| Oct 29SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 86,1544,132,715 held (−2%) | $1.55 | $134K | -36.8% |
- Sell
Director Luke Evnin sold $11K of HOWL at $0.32 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Luke Evnin sold $33K of HOWL at $0.31 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Luke Evnin sold $47K of HOWL at $0.30 — cuts the stake by 52%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Luke Evnin sold $28K of HOWL at $0.37 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Luke Evnin sold $9K of HOWL at $0.44 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Luke Evnin sold $10K of HOWL at $0.40 — pre-scheduled 10b5-1 plan sale.